Mechanisms regulating resistance to inhibitors of topoisomerase II
Inhibitors of topoisomerase II (topo II) are clinically effective in the management of hematological malignancies and solid tumors. The efficacy of anti-tumor drugs targeting topo II is often limited by resistance and studies with in vitro cell culture models have provided several insights on potent...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Media S.A.
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729981/ |